PEX3 Antibody

What is PEX3 and what is its biological significance?

PEX3 (peroxisomal biogenesis factor 3, also known as TRG18) is a 373 amino acid multi-pass membrane protein that anchors to the peroxisomal membrane. It plays an essential role in peroxisome biogenesis and maintenance of peroxisomal integrity . PEX3 functions as a critical docking factor for PEX19 and is required for the import of peroxisomal proteins . From a disease perspective, defects in the gene encoding PEX3 are associated with peroxisome biogenesis disorder complementation group 12 (PBD-CG12) and Zellweger syndrome . Understanding PEX3 is fundamental for researchers studying peroxisome biology, cellular organelle biogenesis, and related metabolic disorders.

What applications are commercially available PEX3 antibodies validated for?

PEX3 antibodies are validated for multiple experimental applications, with specific recommendations based on extensive validation data:

Research-grade antibodies require optimization in each experimental system, and titration is recommended to obtain optimal results based on specific sample types and experimental conditions .

What species reactivity should researchers expect from PEX3 antibodies?

Available PEX3 antibodies show varied species reactivity profiles, which is crucial information for researchers selecting the appropriate reagent for their animal models:

When designing experiments, researchers should consider the evolutionary conservation of PEX3 across species and validate antibody performance in their specific model organism if it hasn't been previously reported in the literature.

What are the optimal protocols for using PEX3 antibodies in Western blot applications?

For Western blot applications using PEX3 antibodies, researchers should consider the following methodological details:

• Sample preparation: PEX3 antibodies have been successfully used with various cell lysates including A431, HEK-293, HepG2, PC-12, and HeLa cells .

• Antibody dilution: The recommended dilution range is 1:500-1:1000 for both 30424-1-AP and 10946-1-AP antibodies .

• Expected molecular weight: Researchers should look for a protein band at approximately 42 kDa, which is the observed molecular weight consistent with the calculated molecular weight of PEX3 .

• Controls: Include appropriate positive controls from validated cell lines (such as HeLa cells for 10946-1-AP or HEK-293 cells for 30424-1-AP) and negative controls (such as PEX3 knockout/knockdown samples if available).

• Optimization: As with all antibody-based applications, researchers should titrate the antibody concentration and adjust incubation conditions for their specific experimental system to achieve optimal signal-to-noise ratios.

What protocol considerations are important for immunohistochemistry with PEX3 antibodies?

For immunohistochemistry applications with PEX3 antibodies (particularly 30424-1-AP), researchers should consider these protocol elements:

• Antigen retrieval methods: For optimal results with mouse kidney tissue, suggested antigen retrieval should be performed with TE buffer pH 9.0. Alternatively, citrate buffer pH 6.0 may be used .

• Antibody dilution: Use a dilution range of 1:50-1:500, with specific dilution optimized based on tissue type and fixation method .

• Validated tissues: Mouse kidney tissue has been validated for IHC applications with 30424-1-AP .

• Signal detection systems: Select an appropriate detection system compatible with rabbit IgG primary antibodies, as PEX3 antibodies are typically rabbit polyclonal antibodies .

• Controls: Include both positive and negative tissue controls. For negative controls, omit primary antibody or use tissues from PEX3 knockout animals if available.

How can researchers analyze PEX3 abundance across different tissues and cell types?

Research has shown that PEX3 abundance varies significantly across different organs and cell types, suggesting tissue-specific regulation of peroxisome biogenesis . When analyzing PEX3 abundance across tissues:

• Comparative analysis approach: Researchers should compare PEX3 levels with other peroxisomal markers (PEX14, ABCD3, catalase) to understand peroxisome heterogeneity in different tissues .

• Methodological considerations:

  • Use freshly isolated tissues or well-characterized cell lines

  • Apply consistent protein extraction protocols across all samples

  • Normalize PEX3 expression to appropriate housekeeping genes or total protein

  • Consider subcellular fractionation to distinguish membrane-bound from soluble pools

• Key findings to contextualize results: Published research demonstrates that "the abundance of PEX3, PEX19, PEX14, ABCD3 and catalase strongly varies in the analysed organs and cell types, suggesting that peroxisome abundance, biogenesis and matrix protein import are independently regulated" .

• Interpretation framework: Variation in PEX3 abundance may indicate differential peroxisome biogenesis rates or turnover across tissues, which has implications for understanding tissue-specific peroxisomal functions and pathologies.

What methods are effective for studying PEX3-protein interactions in living cells?

Based on the research methodologies described in the literature, effective approaches for studying PEX3-protein interactions include:

• Co-immunoprecipitation (Co-IP): This technique has been successfully used to study Pex3 interactions with Atg30 and Atg11 . Key methodological considerations include:

  • Use of appropriate tags (TAP-tag, FLAG-tag) for protein isolation

  • Selection of strains with defects in autophagosome-vacuole fusion (e.g., Δypt7) to accumulate complexes

  • Quantification by densitometry using software like NIH ImageJ

  • Accounting for potential differences in protein expression levels between wild-type and mutant samples

• Yeast two-hybrid analysis: This approach has been used to validate PEX3-Atg30 interactions . Important considerations include:

  • Using full-length proteins or defined domains

  • Including appropriate positive and negative controls

  • Verifying interactions through multiple reporter systems

• Fluorescence microscopy: This has been employed to visualize PEX3 interactions and localization . Key protocol elements include:

  • Z-stack imaging (typically 10 images at 0.2 μm intervals)

  • Deconvolution of images using appropriate software

  • Maintaining consistent microscopy parameters (exposure time, gain) across samples

  • Quantification of colocalization events

These methods provide complementary approaches to understand the dynamic interactions of PEX3 with its binding partners in various cellular contexts.

How do mutations in PEX3 affect its function in peroxisome biogenesis and selective autophagy?

Research on PEX3 mutants has revealed critical insights into its functional domains and mechanisms:

• Identified critical residues: Mutations at Leu-320 and Asn-325 in Pex3 significantly impact its function in pexophagy (selective autophagy of peroxisomes) while maintaining its peroxisome biogenesis function . Specifically:

  • Single mutants (L320P or N325D) showed impaired pexophagy

  • Double mutant (L320P,N325D) demonstrated an exaggerated pexophagy phenotype

  • These mutations affected a structural loop critical for Pex3-Atg30 interaction

• Functional separation: These findings suggest that PEX3 has distinct functional domains for:

  • Peroxisome biogenesis and maintenance

  • Regulation of selective peroxisome degradation (pexophagy)

• Mechanistic insights: The pex3m mutant showed:

  • Reduced interaction with Atg30 based on yeast two-hybrid and co-immunoprecipitation analyses

  • Hypophosphorylation of Atg30

  • Impaired recruitment of Atg11 to the receptor protein complex (RPC)

  • Failure to form the pexophagy-specific PAS (pre-autophagosomal structure)

• Research implications: "We conclude that Pex3 has a role beyond simple docking of Atg30 and that its interaction with Atg30 regulates pexophagy in the yeast P. pastoris" . This indicates that PEX3 actively regulates the phosphorylation status of the pexophagy receptor rather than merely serving as a passive docking site.

How can researchers validate the specificity of PEX3 antibodies?

Proper validation of PEX3 antibodies is critical for ensuring experimental reliability. Researchers should implement the following validation strategies:

• Positive controls: Use cell lines known to express PEX3, such as:

  • A431 cells, HEK-293 cells, HepG2 cells, and PC-12 cells for 30424-1-AP antibody

  • HeLa cells for 10946-1-AP antibody

• Negative controls:

  • PEX3 knockout or knockdown cells/tissues

  • Blocking peptide competition assays using the PEX3 immunogen

  • Secondary antibody-only controls to assess non-specific binding

• Molecular weight verification: Confirm that the detected protein band is at the expected molecular weight of 42 kDa .

• Cross-validation:

  • Compare results using multiple PEX3 antibodies targeting different epitopes

  • Correlate antibody detection with mRNA expression data

  • Verify localization pattern matches known peroxisomal distribution

• Application-specific validation:

  • For IHC: Compare staining patterns with published PEX3 distribution

  • For WB: Verify single band of correct size with minimal background

  • For IF: Confirm colocalization with established peroxisomal markers

What are common challenges when working with PEX3 antibodies and how can they be addressed?

Researchers may encounter several challenges when working with PEX3 antibodies:

• Variability in peroxisome abundance across tissues: As demonstrated in published research, "the abundance of PEX3, PEX19, PEX14, ABCD3 and catalase strongly varies in the analysed organs and cell types" . Researchers should:

  • Adjust protein loading and antibody dilutions based on expected PEX3 expression levels

  • Use positive control samples with known PEX3 expression levels

  • Consider enriching peroxisomal fractions for tissues with low peroxisome abundance

• Subcellular localization challenges:

  • PEX3 is primarily membrane-bound, requiring appropriate detergent-based extraction methods

  • In tissues like heart and skeletal muscle, PEX19 (a PEX3 interacting partner) shows variable ratios of cytosolic to membrane-bound distribution

  • Use subcellular fractionation to distinguish membrane-associated from cytosolic pools

• Post-translational modifications:

  • Consider that PEX3 function may be regulated by protein modifications

  • Phosphorylation of PEX3-interacting proteins (like Atg30) can affect interactions

  • Use phosphatase inhibitors during sample preparation when studying PEX3 complexes

• Experimental conditions for pexophagy studies:

  • When studying PEX3's role in pexophagy, use appropriate medium shifts to induce the process

  • For peroxisome proliferation, methanol medium (8h) has been used successfully

  • For pexophagy induction, transfer to SD−N medium has been employed

How does PEX3 contribute to the regulation of selective autophagy of peroxisomes?

Recent research has revealed that PEX3 plays a more complex role in pexophagy than previously understood:

• Beyond simple docking: PEX3 is not merely a passive docking site for the pexophagy receptor Atg30 but actively regulates the process of selective peroxisome degradation .

• Regulation of receptor phosphorylation: Analysis of Pex3 mutants (specifically mutations at L320P and N325D) demonstrated that:

  • PEX3 influences the phosphorylation status of Atg30

  • Hypophosphorylation of Atg30 was observed in pex3m cells

  • This phosphorylation is critical for Atg30's interaction with Atg11

• Recruitment of selective autophagy machinery: PEX3 indirectly facilitates the recruitment of Atg11 to form the receptor protein complex (RPC):

  • In wild-type cells, GFP-Atg11 relocalized to the vacuole-sequestering membranes in 61±14% of cells

  • In pex3m cells, this relocalization was observed in only 11±7% of cells

  • In Δatg30 cells, relocalization occurred in only 7±6% of cells

• Structural insights: The identified mutations (L320P and N325D) are located in a structural loop that appears critical for mediating Pex3-Atg30 interaction, suggesting a specific interaction domain within PEX3 .

This advanced understanding of PEX3's role provides new avenues for research into the regulation of peroxisome homeostasis and potential therapeutic targets for peroxisomal disorders.

What is known about tissue-specific heterogeneity of peroxisomes regarding PEX3 and other peroxisomal proteins?

Recent research has revealed significant heterogeneity in peroxisome composition across different tissues and cell types:

• Differential abundance patterns: Analysis of mouse organs showed that "the abundance of PEX3, PEX19, PEX14, ABCD3 and catalase strongly varies in the analysed organs and cell types" .

• Independent regulation of peroxisomal processes: The variation in abundance patterns suggests that "peroxisome abundance, biogenesis and matrix protein import are independently regulated" across different tissues .

• PEX19 distribution variability: Research found that "in some organs, such as heart and skeletal muscle, the majority of the shuttling receptor PEX19 is bound to the peroxisomal membrane and that a strong variability exists in the cell type-specific ratio of cytosol- and peroxisome-associated PEX19" .

• Functional implications: The heterogeneity of peroxisomal components suggests tissue-specific adaptations of peroxisome function, potentially related to the metabolic requirements and specializations of different cell types and tissues.

• Research approach: This understanding was developed through generation of antibodies against endogenous mouse PEX3 and PEX19, with subsequent analysis of their abundance and localization across various mouse organs, tissues and cell types, compared with three commonly used peroxisomal markers (PEX14, ABCD3 and catalase) .

These findings highlight the importance of considering tissue context when studying peroxisome biology and suggest that peroxisome function may be more specialized across tissues than previously appreciated.